Inhalation anesthetics – Methoxyflurane MCQs With Answer
Methoxyflurane is a volatile inhalation anesthetic and analgesic important for B. Pharm students studying pharmacology, anesthetic agents, and drug safety. This ether-based inhalational agent has unique pharmacokinetic and metabolic features, including substantial biotransformation producing fluoride ions, which historically limited its use due to nephrotoxicity. Understanding methoxyflurane’s mechanism of action, clinical analgesic applications, adverse effects, monitoring parameters, drug interactions, and safe handling is essential for pharmacists. These focused MCQs cover mechanism, metabolism, dosing concepts, toxicities, and clinical considerations to strengthen exam preparation and practical knowledge of inhalation anesthetics. Now let’s test your knowledge with 50 MCQs on this topic.
Q1. Which class of agents does methoxyflurane belong to?
- Volatile inhalational anesthetic (ether derivative)
- Intravenous opioid analgesic
- Local anesthetic ester
- NMDA receptor antagonist
Correct Answer: Volatile inhalational anesthetic (ether derivative)
Q2. The primary mechanism of action for most inhalation anesthetics, including methoxyflurane, involves:
- Inhibition of acetylcholinesterase
- Potentiation of GABA_A receptor-mediated inhibition
- Activation of opioid receptors in the brainstem
- Blockade of voltage-gated sodium channels
Correct Answer: Potentiation of GABA_A receptor-mediated inhibition
Q3. Which major toxic metabolite is produced during methoxyflurane metabolism that contributes to renal injury?
- Acetaldehyde
- Inorganic fluoride ions
- Formaldehyde
- Chloroform
Correct Answer: Inorganic fluoride ions
Q4. Historically, methoxyflurane was withdrawn as a routine general anesthetic primarily because of:
- High risk of malignant hyperthermia
- Severe cardiotoxicity leading to arrhythmias
- Nephrotoxicity associated with metabolites
- Poor potency compared with other agents
Correct Answer: Nephrotoxicity associated with metabolites
Q5. In current clinical practice, low-dose methoxyflurane is often used for:
- Long-term maintenance anesthesia during surgery
- Rapid sequence induction for intubation
- Short-term analgesia in prehospital and emergency care
- Chronic pain management in outpatient clinics
Correct Answer: Short-term analgesia in prehospital and emergency care
Q6. Which organ system should be monitored most closely when methoxyflurane is administered at analgesic or anesthetic doses?
- Hematologic system
- Renal function
- Gastrointestinal tract
- Musculoskeletal system
Correct Answer: Renal function
Q7. Methoxyflurane metabolism primarily occurs in the:
- Kidney via renal dehydrogenases
- Liver via cytochrome P450 enzymes
- Plasma via esterases
- Lungs via alveolar enzymes
Correct Answer: Liver via cytochrome P450 enzymes
Q8. Which cytochrome P450 isoform is most commonly implicated in metabolism of halogenated inhalational anesthetics?
- CYP3A4
- CYP2E1
- CYP1A2
- CYP2D6
Correct Answer: CYP2E1
Q9. The term MAC (minimum alveolar concentration) refers to:
- The concentration producing surgical anesthesia in 50% of patients
- The concentration below which no analgesia occurs
- The blood concentration at which toxicity begins
- The solvent capacity of the anesthetic in blood
Correct Answer: The concentration producing surgical anesthesia in 50% of patients
Q10. Compared with modern volatile agents like sevoflurane, methoxyflurane is characterized by:
- Lower metabolism and minimal fluoride production
- Higher lipid solubility and greater metabolism to fluoride
- Complete lack of renal adverse effects
- Exclusive renal excretion without hepatic metabolism
Correct Answer: Higher lipid solubility and greater metabolism to fluoride
Q11. A pharmacist advising on methoxyflurane use should warn patients about which common acute side effects?
- Visual hallucinations and kidney stones
- Dizziness, sedation, nausea
- Orthostatic hypotension and bradycardia only after weeks
- Permanent hearing loss
Correct Answer: Dizziness, sedation, nausea
Q12. Which patient condition is a relative contraindication to methoxyflurane use due to increased risk?
- Well-controlled hypertension
- Pre-existing renal impairment
- Mild seasonal allergy
- Stable hypothyroidism
Correct Answer: Pre-existing renal impairment
Q13. The analgesic effect of low-dose methoxyflurane in emergency settings is primarily due to:
- Peripheral opioid receptor activation
- CNS depression and modulation of nociceptive pathways
- Direct local anesthetic action on peripheral nerves
- Anti-inflammatory effects in injured tissues
Correct Answer: CNS depression and modulation of nociceptive pathways
Q14. Occupational exposure to methoxyflurane vapors can be minimized by:
- Using scavenging systems and well-ventilated areas
- Wearing latex gloves only
- Storing ampoules at high temperature
- Administering only in closed operating rooms without ventilation
Correct Answer: Using scavenging systems and well-ventilated areas
Q15. Which laboratory marker may rise as a result of significant methoxyflurane metabolism?
- Serum potassium concentration
- Serum inorganic fluoride level
- Serum amylase
- Fasting blood glucose
Correct Answer: Serum inorganic fluoride level
Q16. Methoxyflurane use in pregnancy is categorized with caution because:
- It is a proven teratogen in low doses
- Limited data exist and fetal effects at high anesthetic doses are possible
- It causes immediate uterine contractions
- It is rapidly converted to glucose in the placenta
Correct Answer: Limited data exist and fetal effects at high anesthetic doses are possible
Q17. One pharmacokinetic property that contributes to methoxyflurane’s potency is:
- Low blood:gas partition coefficient
- High blood:gas partition coefficient
- High renal clearance
- No tissue solubility
Correct Answer: High blood:gas partition coefficient
Q18. Which monitoring parameter is essential during methoxyflurane administration for analgesia in emergency care?
- Capillary refill time only
- Consciousness level, respiratory rate, and oxygen saturation
- Daily complete blood count
- Fasting lipid profile
Correct Answer: Consciousness level, respiratory rate, and oxygen saturation
Q19. The primary route of elimination for unmetabolized methoxyflurane is:
- Renal excretion of unchanged drug
- Exhalation via the lungs
- Biliary excretion into feces
- Metabolism to glucose and urinary excretion
Correct Answer: Exhalation via the lungs
Q20. Which statement about methoxyflurane’s efficacy as an analgesic at low-dose inhalation is true?
- It provides long-term chronic pain relief after a single dose
- It offers rapid-onset, short-duration analgesia useful for procedures
- It is only effective when combined with intravenous opioids
- It lacks any analgesic properties at subanesthetic doses
Correct Answer: It offers rapid-onset, short-duration analgesia useful for procedures
Q21. Compared to non-fluorinated inhalational agents, fluorinated ethers like methoxyflurane tend to:
- Be completely metabolized to harmless products
- Have increased chemical stability and potential for fluoride production
- Have no impact on renal or hepatic systems
- Always produce less potent anesthesia
Correct Answer: Have increased chemical stability and potential for fluoride production
Q22. In the context of drug interactions, concurrent use of enzyme inducers (e.g., chronic ethanol) may:
- Decrease methoxyflurane metabolism and increase toxicity
- Increase metabolism leading to more toxic metabolites
- Have no effect on methoxyflurane metabolism
- Neutralize methoxyflurane via direct chemical reaction
Correct Answer: Increase metabolism leading to more toxic metabolites
Q23. Which of the following best describes a safe pharmacy counselling point for outpatient methoxyflurane analgesic use (where permitted)?
- Use multiple doses back-to-back without guidance
- Avoid driving or operating machinery while under its effects
- Store opened inhaler in direct sunlight for potency
- Combine with high-dose sedatives for better effect
Correct Answer: Avoid driving or operating machinery while under its effects
Q24. A distinctive historical adverse syndrome linked to methoxyflurane exposure is:
- Halothane hepatitis
- Nephrotoxicity with polyuria and elevated serum fluoride
- Acute pancreatitis in all patients
- Immediate irreversible blindness
Correct Answer: Nephrotoxicity with polyuria and elevated serum fluoride
Q25. Which formulation of methoxyflurane is commonly used for analgesia in emergency settings in some countries?
- Intravenous bolus solution
- Self-administered inhaler (Penthrox™ or similar)
- Topical cream
- Oral tablets
Correct Answer: Self-administered inhaler (Penthrox™ or similar)
Q26. In toxicology, high levels of fluoride from volatile anesthetic metabolism primarily affect:
- Cardiac conduction system exclusively
- Renal tubular cells causing nephrotoxicity
- Oligodendrocytes in the CNS
- Pancreatic islet cell insulin secretion
Correct Answer: Renal tubular cells causing nephrotoxicity
Q27. Pharmacists should be aware that methoxyflurane metabolism may be increased by which condition?
- Liver cirrhosis leading to decreased metabolism
- Concurrent administration of CYP2E1 inducers like chronic alcohol use
- Hypothermia which doubles metabolism
- Renal dialysis which activates hepatic enzymes
Correct Answer: Concurrent administration of CYP2E1 inducers like chronic alcohol use
Q28. Which clinical sign would most suggest developing methoxyflurane-related renal toxicity?
- Progressive oliguria and rising serum creatinine
- Improved urine output with decreased creatinine
- Isolated cough without other changes
- Sudden hair loss
Correct Answer: Progressive oliguria and rising serum creatinine
Q29. When comparing environmental impact, volatile anesthetics including methoxyflurane are of concern due to:
- Contribution to greenhouse gas emissions and atmospheric persistence
- Rapid biodegradation making them harmless
- Exclusive conversion to water vapor
- No measurable atmospheric effects
Correct Answer: Contribution to greenhouse gas emissions and atmospheric persistence
Q30. For B. Pharm students, which practical point about handling methoxyflurane in pharmacy practice is important?
- It can be safely disposed of down the sink
- Use designated containment and follow hazardous waste guidelines
- Store it with food items in patient kitchens
- Label it as an oral medication for staff convenience
Correct Answer: Use designated containment and follow hazardous waste guidelines
Q31. The analgesic duration from a single small inhaler dose of methoxyflurane in emergency use is typically:
- Many days of continuous analgesia
- Short, often tens of minutes to under an hour
- Instantaneous and permanent pain resolution
- No analgesic effect at any dose
Correct Answer: Short, often tens of minutes to under an hour
Q32. Which patient population requires extra caution or avoidance of methoxyflurane use?
- Patients with mild seasonal allergies only
- Patients with significant renal impairment or pre-existing kidney disease
- Children under normal conditions with no other issues
- Healthy adults with normal renal and hepatic function
Correct Answer: Patients with significant renal impairment or pre-existing kidney disease
Q33. Which monitoring is most appropriate after a patient receives repeated doses of methoxyflurane?
- Daily ECG monitoring for a month
- Serial renal function tests (serum creatinine, urine output)
- Immediate liver biopsy
- No monitoring is ever required
Correct Answer: Serial renal function tests (serum creatinine, urine output)
Q34. Which of the following best explains why methoxyflurane produces more toxic metabolites than some modern agents?
- It undergoes a greater proportion of hepatic biotransformation
- It is never metabolized and accumulates unchanged
- It is metabolized only to harmless water
- It is excreted entirely via feces without metabolism
Correct Answer: It undergoes a greater proportion of hepatic biotransformation
Q35. Which sign is NOT typically associated with acute methoxyflurane overexposure?
- Excessive sedation and respiratory depression
- Nausea and dizziness
- Persistent severe polyuria with renal dysfunction
- Rapid hair and nail growth
Correct Answer: Rapid hair and nail growth
Q36. For exam preparation, B. Pharm students should remember that methoxyflurane is structurally classified as:
- An aliphatic amine
- A fluorinated methylated ether
- A benzodiazepine derivative
- A peptide opioid
Correct Answer: A fluorinated methylated ether
Q37. Which of the following interventions is most appropriate if a patient develops signs of methoxyflurane-induced renal impairment?
- Immediate increase of methoxyflurane dose
- Discontinue exposure, supportive care, monitor renal function, consult nephrology
- Administer high-dose methoxyflurane antidote
- Ignore and continue outpatient analgesia
Correct Answer: Discontinue exposure, supportive care, monitor renal function, consult nephrology
Q38. Which pharmacologic property contributes to the rapid onset of inhalation anesthetics in general?
- High hepatic extraction ratio
- Low alveolar partial pressure relative to brain
- High alveolar ventilation and favorable blood-gas partitioning
- Slow diffusion across the alveolar membrane
Correct Answer: High alveolar ventilation and favorable blood-gas partitioning
Q39. In understanding adverse effects, formation of nephrotoxic metabolites from methoxyflurane is dose-dependent because:
- Metabolism increases with higher exposure producing more toxic fluoride
- Metabolism decreases with higher exposure preventing toxicity
- Toxicity is unrelated to dose or metabolism
- Higher doses are always safer
Correct Answer: Metabolism increases with higher exposure producing more toxic fluoride
Q40. Which statement about methoxyflurane’s cardiac effects is correct?
- It consistently causes severe myocardial necrosis
- At clinical analgesic doses, major cardiotoxicity is uncommon
- It is a direct inotrope that increases cardiac output dramatically
- It irreversibly blocks beta-adrenergic receptors
Correct Answer: At clinical analgesic doses, major cardiotoxicity is uncommon
Q41. Which monitoring technique is useful to assess adequate ventilation in a patient receiving inhaled methoxyflurane analgesia?
- Continuous pulse oximetry and clinical observation of respiratory rate
- Weekly chest X-ray
- Only subjective patient report without objective measures
- Serum fluoride measurement every 5 minutes
Correct Answer: Continuous pulse oximetry and clinical observation of respiratory rate
Q42. Which regulatory consideration is important when dispensing methoxyflurane inhalers for analgesia?
- There are no regulatory restrictions anywhere
- Follow country-specific approvals and restrict use to indicated settings
- They are available over the counter without restriction
- They can be refilled indefinitely without prescription
Correct Answer: Follow country-specific approvals and restrict use to indicated settings
Q43. Which chemical feature of methoxyflurane increases its potency as an inhalational agent?
- High molecular polarity preventing CNS entry
- High lipid solubility facilitating CNS penetration
- Being a large protein molecule
- Complete ionization at physiologic pH
Correct Answer: High lipid solubility facilitating CNS penetration
Q44. For B. Pharm exam questions, which comparison is accurate: methoxyflurane vs. isoflurane?
- Methoxyflurane is less metabolized than isoflurane
- Methoxyflurane undergoes more hepatic metabolism and produces more fluoride
- Both agents are identical in metabolism and toxicity
- Isoflurane produces more fluoride than methoxyflurane in all cases
Correct Answer: Methoxyflurane undergoes more hepatic metabolism and produces more fluoride
Q45. Which laboratory test would a pharmacist recommend if a patient had multiple methoxyflurane exposures and symptoms suggest renal injury?
- Urinalysis and serum creatinine measurement
- Serum cholesterol panel
- Skin allergy testing
- ECG only without labs
Correct Answer: Urinalysis and serum creatinine measurement
Q46. Which statement about recovery after single low-dose methoxyflurane analgesia is true?
- Patients typically experience prolonged recovery lasting days
- Recovery is usually rapid once inhalation stops with resolution of CNS effects
- Recovery requires dialysis to remove the drug
- There is no possibility of transient sedation
Correct Answer: Recovery is usually rapid once inhalation stops with resolution of CNS effects
Q47. Methoxyflurane may enhance the effects of which class of drugs, increasing sedation risk?
- Stimulant sympathomimetics
- CNS depressants such as benzodiazepines and opioids
- Topical antihistamines only
- Proton pump inhibitors exclusively
Correct Answer: CNS depressants such as benzodiazepines and opioids
Q48. Which precaution is important when educating staff about methoxyflurane inhaler disposal?
- Return partially used inhalers to patient home storage
- Follow hazardous waste protocols and manufacturer instructions for disposal
- Pour remaining contents into sink and rinse
- Burn inhalers in open air to remove vapors
Correct Answer: Follow hazardous waste protocols and manufacturer instructions for disposal
Q49. In developing exam-style MCQs, which integrative concept regarding methoxyflurane is valuable for B. Pharm students?
- Only memorizing brand names without mechanism or safety
- Understanding mechanism, metabolism, adverse effects, monitoring, and regulatory use
- Focusing exclusively on economic cost without safety aspects
- Assuming all inhalational agents are interchangeable clinically
Correct Answer: Understanding mechanism, metabolism, adverse effects, monitoring, and regulatory use
Q50. Which research or clinical consideration remains important for methoxyflurane use in modern practice?
- Evaluating long-term renal outcomes after repeated low-dose exposures
- Assuming no monitoring is needed for any exposure
- Replacing all analgesics with methoxyflurane universally
- Neglecting environmental scavenging and workplace safety
Correct Answer: Evaluating long-term renal outcomes after repeated low-dose exposures

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com

